• Latest Posts
Opinion 6 Sep 2022

Meeting tech transfer challenges when manufacturing new biopharmaceuticals

CellOrigin Biotech and Qilu Pharmaceutical to develop CAR-iMAC cell therapy

Neukio Biotherapeutics completes financing round for development of cell therapy products

Interview 31 Aug 2022

How CDMOs keep pace with trends in advanced therapies

Laverock Therapeutics created to develop next generation of programmable cell therapies

Zelluna Immunotherapy announces investment from Takeda Ventures, Inc.

ADVERTISEMENT

Gene therapies for lung cancer identified by international team of scientists

Stem cell therapy to be used in treatment of long COVID by Panacell Biotech

Allogenic immune cell therapies to be developed as three groups join forces

RoslinCT and Lykan Bioscience combine to create cell therapy CDMO

Enrollment completed for trial looking at treatment of diabetic kidney disease

Clinical hold on trial for colorectal cancer drug lifted by FDA

ADVERTISEMENT